Meet the Expert: Radiological Challenges in Lung Cancer
Erin JungmeyerDr. Ioannis Vlahos will address issues radiologists encounter in applying TNM staging guidelines in daily practice. Read more
Self-Learning AI as a Diagnostic Tool in Malignant Mesothelioma
Erin JungmeyerProf. John Le Quesne will show how AI can be used to subtype mesothelioma into risk categories and prognosis. Read more
IASLC Journals See Continued Success Throughout Past Year
Bailey CreamerEditors-in-Chief Drs. Alex A. Adjei and Emily Stone will talk with members during a Meet-the-Editor session on Monday afternoon. Read more
Hands-on Workshop Outlines Challenges and Potential Solutions for Translating Early Detection Biomarkers From Discovery to Lung Cancer Clinical Practice
Krithika Subramanian, PhDAn expert panel from the US National Cancer Institute’s Early Detection Research Network provided insights into the current state of the art as well as barriers to use. Read more
Updated Biomarker Survey Results Show Paradigm Shift As More Respondents Now Consider Testing a “Must Have”
Fred GebhartHowever, lead author Dr. Matthew Smeltzer said the new data also show clinicians value biomarker testing more in late-stage disease compared to early-stage disease. Read more
9th Edition Lung Cancer Staging Recommendations to be Explained
Fred GebhartDuring the session, experts will not only review the updates, they will also discuss how they approached the process and the guidelines’ limitations. Read more
Special Plenary to Focus on IASLC’s Role in Shaping Thoracic Cancer Research, Treatment
Fred GebhartFormer IASLC CEO Dr. Paul A. Bunn, Jr., says lung cancer is a global challenge and the unique multinational and multi-specialty nature of the IASLC has helped to build a global response. Read more
The WCLC 2024 program includes several opportunities to browse posters and see the latest in thoracic oncology research. Read more
First Presidential Symposium to Explore Practice-Changing Research in Lung Cancer Screening, Immune Oncology
Fred GebhartThe session will also include late-breaking data from HARMONi-2, NeoCOAST-2, and TROPION-Lung01 as well as an address from IASLC President Dr. Paul Van Schil. Read more
Action Needed to Improve Gender Equity in Thoracic Oncology
Fred GebhartWhile women remain a minority in thoracic oncology, Drs. Narjust Florez and Linda Martin say change is happening. The duo will co-chair a special session designed to address issues faced by women in the field. Read more